Regulatory Affairs

FDA FDA Approval Drug Approval FDA Approvals Drug Approval Process FDA Approval Process FDA Regulations Global Health Policies FDA Guidelines Medical Products US Food and Drug Administration Drug Approvals Medical Cannabis Drug Regulation AIFA FDA Designations Food Regulations European Medicines Agency Marketing Authorization Accelerated Approval FDA Actions Vaccine Approval

FDA Recalls Specific FreeStyle Libre 3 Sensors Over Faulty Low-Glucose Readings

Regulators specified the affected Libre 3 sensors following reports of falsely low readings linked to serious harm.

Sarepta Reports 3-Year EMBARK Data Showing Elevidys Slows Duchenne Progression

Daré Bioscience Launches Topical Sildenafil Cream for Female Arousal

Dyne’s DMD Drug Hits Primary Endpoint in DELIVER REC, Shows Functional Gains

Bristol Myers Delays ADEPT-2 Alzheimer’s Psychosis Readout to 2026 After Site Irregularities

Bayer Stroke Drug Asundexian Hits Phase III Goals, Shares Jump

Agios’ Sickle Cell Pill Lifts Hemoglobin but Misses Pain-Crisis Goal in Phase 3

Cannabis Extract VER-01 Eases Chronic Low Back Pain in Phase 3 Trial

FDA Approves Palsonify, First Once-Daily Oral Treatment for Acromegaly

EU Regulators Back Uplizna as First Treatment for IgG4‑Related Disease

CSL Secures VarmX Acquisition Option, Funding Phase 3 of Factor Xa Reversal Drug

FDA Approves First New Fibromyalgia Treatment in 15 Years

Hims & Hers Plans Canadian Launch of Generic Semaglutide After Zava Acquisition

Leukemia-on-a-Chip Enables Rapid, Scalable CAR T-Cell Therapy Screening

FDA Warns of Rare Severe Itching After Stopping Common Allergy Medications